With a market cap of $18.4 billion, Zimmer Biomet Holdings, Inc. (ZBH) is a leading global medical technology company specializing in orthopedic implants and surgical solutions. The Indiana-based  company’s portfolio includes joint replacement products, trauma and sports medicine devices, spine and craniomaxillofacial technologies, and robotic surgery platforms. Companies worth more than $10 billion are generally labeled as “large-cap” stocks and Zimmer Biomet fits this criterion perfectly. Serving hospit ...

Company Overview - Bioventus is a $550 million medical device company operating in large and growing markets [4] - The company focuses on pain management, surgical solutions, and restorative therapies [4] - Bioventus believes it has better opportunities for creating shareholder value compared to other small mid-cap stocks [4] Market Position and Growth - The company has a diversified portfolio and is either a category leader or a growth leader in its segments [5] - Bioventus has demonstrated strong execution with 7 quarters of above mid-single-digit growth, including 4 quarters of double-digit growth [5]